Press

Maschinenraum, the ecosystem transforming German-speaking family businesses, is allying with Germany’s leading venture capitalists (VCs). The strategic partnerships allow the now nearly 70 family-owned companies to directly engage with renowned venture capitalists and start-ups to better prepare for the future. For the cross-industry network of family businesses, the partnerships are another opportunity to jointly solve the most pressing questions and tasks of forward-looking transform

Potsdam, Germany – April 24, 2023 – DearEmployee, the innovation leader in HR tech, announces the closing of a pre-Series A round. In particular, the fresh capital from new and existing investors will be used to further expand the functionality of the software solution along customer needs and to build the processes and structures for further growth, including the future location in Potsdam. Mental illnesses are the most common reason for loss of working capacity and contribut

Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation. The startup closes a 600,000 € pre-seed financing round with High-Tech Gründerfonds. The capital will be used to further develop Phialogics’ lead candidate in preclinical models in comparison to the current standard of care and other research approaches. This is a step forward to continue developing Phialogics’ i

Future Energy Ventures, Triodos Energy Transition Europe Fund and existing Sunvigo shareholders invest EUR 12 million growth capital DKB AG provides another EUR 7.5 million to finance Sunvigo’s residential solar PV systems, batteries and e-vehicle charging solutions Sunvigo to use growth funding to scale its smart solar-as-a-service proposition and further develop its virtual power plant Cologne 18th of April, 2023 – Leading greentech investors Future Energy Ventures (

Proceeds will fund: Clinical programs ALE.F02 and ALE.C04 – two first-in-class anti-Claudin-1 (CLDN1) antibodies for organ fibrosis and CLDN1 positive tumors The platform to engineer CLDN1 antibody drug conjugates (ADC) and bispecific antibodies Basel, Switzerland – 13 April 2023, Alentis Therapeutics (“Alentis”), the Claudin-1 (CLDN1) company, is a clinical-stage biotech company developing breakthrough treatments for organ fibrosis and CLDN1 positive tumors. Today, A

Company pursuing a highly differentiated small molecule MOS-118 in Metabolic Obstructive Sleep Apnea. New investors, Supermoon Capital and HTGF, join founding investor Forty51 Ventures to complete the Seed syndicate. Company will use the funds to file an IND in preparation for a proof of mechanism and proof of concept in the clinic. Basel, Switzerland, April 11, 2023 – Mosanna Therapeutics AG, a Swiss Biotech company today announced that Supermoon Capital, a US based ven

Bonn, 4 April 2023 – Dr. Ulrich Schmitt (37) has been appointed a new Partner at High-Tech Gründerfonds (HTGF), one of Europe’s leading seed investors, with effect from 1 April 2023. The former management consultant has been a member of HTGF’s digital tech team since 2017, most recently as Principal. His investments have been focused on the field of B2B software, particularly in the areas of cyber security, IT infrastructure and fintech. His portfolio of companies includes cy

talpasolutions is key enabler for customers in mining, construction, and logistics towards a fully optimized, safe, and sustainable equipment fleet. The financing round is led by Bosch Ventures and MIG Capital with the participation of all existing investors. The company will use this financing to enhance its industrial intelligence platform and expand its footprint from mining into construction, logistics and other heavy industries. HTGF has been invested in talpasolutions since 2

Munich, Germany, 23 March 2023 – mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced today the first closing of EUR 13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the funding round together with a pool of private seed investors. mbiomics uses its proprietary, tailored high-resolution profiling platform and computat

Covalo is currently one of the world’s largest Personal Care ingredients platforms with over 70,000 listings from more than 1,000 suppliers. Covalo is already used by formulators from more than 5,000 brands such as Lush, L’Oréal or Drunk Elephant across 140 countries. Covalo has established strong ties with key industry associations such as COSMED in France, SKW in Switzerland, the leading fair organizer (Reed Exhibitions), as well as some of the major PLM (product life-cycle man

Zurich, March 16, 2023 – lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography®, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuring viral load in cell & gene therapy manufacturing, and testing for off-target respo

Karlsruhe, 16. März, 2023 –Phytonics, a pioneer in the field of PV module coating, has successfully closed a seven-digit Seed funding round. High-Tech Gründerfonds (HTGF), one of Europe’s leading seed investors, EIT InnoEnergy, the innovation engine for sustainable energy across Europe, as well as the renowned Karlsruhe Institute of Technology (KIT) and business angels are participating in the round. The new capital will be used for further development and market launch of the

ConTech start-up oculai secures €2.5 million during seed financing round The financing round was led by High-Tech Gründerfonds (HTGF), with Bayern Kapital, Axeleo Capital, and other renowned private investors and an accelerator program also taking part This is the 700th seed investment of High-Tech Gründerfonds oculai is a technology for automated process and progress monitoring for construction sites Munich, 14 March 2023- oculai has secured €2.5 millio

AICA SA receives CHF 1.2 million in Seed round from Spicehaus Partners, High-Tech Gründerfonds, and Schaeffler Group. The Swiss startup uses Artificial Intelligence to automate manufacturing processes that are complex and hard for people to accomplish. The raised funds will allow the EPFL spin-off to expand its library of applications and deploy its solutions internationally. Lausanne, Switzerland, 8 March 2023 – The Lausanne-based EPFL-Spin Off from the LASA, which aim

Toolify’s XITO is a one-stop shop for individual automation solutions using robots, designed specifically for small and medium-sized enterprises. The holistic solution enables companies to quickly, easily, and cost-effectively initiate robot-assisted automation of manual tasks. The raised capital from the seed round with High-Tech Gründerfonds will be used to enhance product development and expand sales activities. Ulm, 2 March 2023 –The Ulm-based start-up Toolify, fo

High-Tech Gründerfonds’ fourth fund (HTGF IV) reaches a final volume of 493.8 million euros. This makes it the biggest fund generation in the seed investor’s history. Alexa Gorman, Senior Vice President SAP.iO at SAP SE, is to become deputy chair of the investor advisory board. Alongside the Federal Ministry for Economic Affairs and Climate Action (BMWK) and KfW Capital, 45 private companies have invested in HTGF IV. Bonn, 28 February 2023 – High-Tech Gründerf